TLDR
- AVAV rose 2.9% to $148.78 on Tuesday on above-average volume, but trades below both its 50-day ($160.13) and 200-day ($181.64) moving averages.
- Q1 2027 earnings are due Wednesday, September 9th after market close, with EPS consensus at $0.25, down 21.9% year over year.
- Revenue estimate for Q1 stands at $456.09M, just 0.3% above the same period last year.
- Over the past 3 months, EPS estimates saw 11 downward revisions and zero upward, with revenue estimates following the same pattern.
- Analysts still rate AVAV a “Moderate Buy” with an average price target of $266.68, well above current trading levels.
AeroVironment is set to report Q1 2027 earnings after the bell on Wednesday, September 9th. Analysts are expecting EPS of $0.25, which would represent a 21.9% drop compared to the same quarter last year.
Revenue expectations sit at $456.09 million, nearly flat year over year with just a 0.3% increase projected.
The stock closed Tuesday at $148.78, after trading as high as $152.20 during the session. Volume came in at roughly 1.98 million, about 24% above the daily average.
Despite Tuesday’s move, AVAV remains well below its 50-day moving average of $160.13 and its 200-day moving average of $181.64. That puts the stock in a technically weak position heading into the print.
Estimate Revisions Tell a Cautious Story
The revision trend heading into this report is not encouraging. Over the past three months, EPS estimates have seen 11 downward revisions and zero upward. Revenue estimates followed the same path, with 10 cuts and no increases.
That kind of one-sided revision activity usually signals analysts are skeptical about near-term results.
Still, AVAV has a solid history of beating on revenue. Over the past two years, the company has topped revenue estimates 75% of the time. EPS beats are less consistent, coming in at just 38% over the same period.
Last quarter, the company delivered a strong beat. Q4 EPS came in at $1.84 against expectations of $1.47, and revenue hit $641.62 million versus the $555.97 million consensus, up 133.3% year over year.
That was a standout quarter. Q1 expectations are far more modest by comparison.
Analyst Targets Remain Well Above Current Price
Despite several price target cuts in recent months, Wall Street’s overall view on AVAV remains positive. The consensus rating is “Moderate Buy,” with 18 Buy ratings, 2 Strong Buys, 3 Holds, and 1 Sell.
The average price target sits at $266.68, a steep premium to where the stock is trading now.
Canaccord Genuity trimmed its target from $280 to $240 in July but kept a Buy rating. Stifel Nicolaus cut from $315 to $220, also maintaining Buy. Piper Sandler moved its target from $248 to $235 with an Overweight rating. Wedbush started coverage with an Outperform and a $250 target.
Institutional ownership stands at 86.38%. Insiders, however, have been net sellers, with 705 shares sold over the last three months worth roughly $132,979.
The company’s FY2027 EPS guidance range is $3.02 to $3.34, with sell-side consensus around $3.20 for the full year.
Wednesday’s report will show whether Q1 sets AVAV on track to hit those full-year numbers.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







